BURNING ROCK BIOTECH LTD's ticker is BNR and the CUSIP is 12233L107. A total of 50 filers reported holding BURNING ROCK BIOTECH LTD in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $633,712 | -56.0% | 667,065 | 0.0% | 0.01% | -46.7% |
| Q2 2023 | $1,440,860 | -19.3% | 667,065 | +1.7% | 0.02% | -28.6% |
| Q1 2023 | $1,784,633 | +12.6% | 656,115 | -8.1% | 0.02% | -8.7% |
| Q4 2022 | $1,585,136 | -7.5% | 714,025 | -3.7% | 0.02% | +4.5% |
| Q3 2022 | $1,714,000 | -22.1% | 741,830 | -1.5% | 0.02% | -18.5% |
| Q2 2022 | $2,199,000 | -89.0% | 753,004 | -64.6% | 0.03% | -81.6% |
| Q1 2022 | $19,989,000 | +166475.0% | 2,126,513 | +81.4% | 0.15% | – |
| Q4 2021 | $12,000 | -99.9% | 1,172,542 | +27.5% | 0.00% | -100.0% |
| Q3 2021 | $16,090,000 | -25.9% | 919,425 | +20.7% | 0.07% | -18.8% |
| Q2 2021 | $21,718,000 | -6.6% | 761,503 | -11.8% | 0.08% | -25.4% |
| Q1 2021 | $23,241,000 | +150.7% | 863,343 | +115.1% | 0.11% | +115.1% |
| Q4 2020 | $9,270,000 | – | 401,292 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 217,728 | $5,030,000 | 2.29% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,685,908 | $38,944,000 | 2.07% |
| Casdin Capital, LLC | 1,922,150 | $44,402,000 | 1.32% |
| Orbimed Advisors | 4,161,675 | $96,135,000 | 0.84% |
| INDUS CAPITAL PARTNERS, LLC | 144,580 | $3,340,000 | 0.52% |
| Aspex Management (HK) Ltd | 486,418 | $11,236,000 | 0.44% |
| HSG Holding Ltd | 212,121 | $4,900,000 | 0.41% |
| MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 15,100 | $349,000 | 0.39% |
| HAMILTON LANE ADVISORS LLC | 44,416 | $1,026,000 | 0.38% |
| Monashee Investment Management LLC | 80,000 | $1,848,000 | 0.24% |